According to a report from Globe Newswire on January 13th, the U.S. Food and Drug Administration's (FDA) proposal to reduce the nicotine content in cigarettes has been approved by the Office of Management and Budget (OMB) on January 3rd, 2025. An FDA spokesperson stated that this policy may be one of the most impactful population-level actions in the history of U.S. tobacco product regulation.
The proposal aims to significantly reduce the nicotine content in cigarettes. 22nd Century Group, Inc., a US tobacco company, announced its support for the proposal and is prepared to provide necessary support. The company claims that its VLN brand of low-nicotine cigarettes aligns well with the proposal.
Larry Firestone, CEO of 22nd Century Group, Inc., stated that...
The approval of OMB marks an important step forward for this policy. We look forward to the federal government taking further concrete actions to make this science-supported, non-partisan policy to reduce smoking harm a reality.
Since 2009, 22nd Century Group, Inc. has been conducting and developing various federally funded clinical studies to advance this policy. The company became the first to receive FDA authorization to launch low-nicotine cigarettes aimed at reducing smoking harm by introducing VLN low-nicotine cigarettes. Currently, the company is working on launching more low-nicotine products while promoting low-nicotine cigarettes as a standalone category in the market.
According to reports, 22nd Century Group, Inc. is a tobacco company based in the United States that specializes in the sales and distribution of its own patented new low-nicotine tobacco products. The company claims that the nicotine content of its flagship product, VLN cigarettes, is 95% lower than traditional cigarettes.
We welcome news tips, article submissions, interview requests, or comments on this piece.
Please contact us at info@2firsts.com, or reach out to Alan Zhao, CEO of 2Firsts, on LinkedIn
Notice
1. This article is intended solely for professional research purposes related to industry, technology, and policy. Any references to brands or products are made purely for objective description and do not constitute any form of endorsement, recommendation, or promotion by 2Firsts.
2. The use of nicotine-containing products — including, but not limited to, cigarettes, e-cigarettes, nicotine pouchand heated tobacco products — carries significant health risks. Users are responsible for complying with all applicable laws and regulations in their respective jurisdictions.
3. This article is not intended to serve as the basis for any investment decisions or financial advice. 2Firsts assumes no direct or indirect liability for any inaccuracies or errors in the content.
4. Access to this article is strictly prohibited for individuals below the legal age in their jurisdiction.
Copyright
This article is either an original work created by 2Firsts or a reproduction from third-party sources with proper attribution. All copyrights and usage rights belong to 2Firsts or the original content provider. Unauthorized reproduction, distribution, or any other form of unauthorized use by any individual or organization is strictly prohibited. Violators will be held legally accountable.
For copyright-related inquiries, please contact: info@2firsts.com
AI Assistance Disclaimer
This article may have been enhanced using AI tools to improve translation and editorial efficiency. However, due to technical limitations, inaccuracies may occur. Readers are encouraged to refer to the cited sources for the most accurate information.
We welcome any corrections or feedback. Please contact us at: info@2firsts.com
